The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...

Pfizer CEO Albert Bourla joins CNBC's 'Special Report' as President-elect Donald Trump is inaugurated as the 47th U.S.

President Trump has vowed to impose tariffs on China, Mexico, and Canada. They could make common medicines less affordable.

The guidelines are a first-of-its-kind effort to establish recommendations for the medical management of HS in seven ...

The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light.

It's the start of a new year, and that makes now the perfect time to load up on stocks that could boost your portfolio in ...

In 2024, companies in the broader market that paid dividends returned around 35% of their net income and 45% of their free ...

The general mood among these heavyweight investors is divided, with 33% leaning bullish and 50% bearish. Among these notable ...

We recently compiled a list of the 10 Best High-Yield Dividend Stocks To Invest In. In this article, we are going to take a ...

Pfizer Inc. ( NYSE:PFE ) will increase its dividend from last year's comparable payment on the 7th of March to ...

We rate BioNTech SE a hold due to volatile performance, weak growth, and premium valuation amidst COVID-19 vaccine reliance.